Key Takeaways:
- Aurora Cannabis reported Q4 EPS of $0.10, beating the -$0.09 consensus estimate
- Revenue reached $91 million, topping the $76.5 million forecast by 19%
- The cannabis producer swung to profitability on stronger sales and cost controls
Back
Aurora Cannabis beats Q4 estimates with $0.10 EPS, revenue up 19%
Aurora Cannabis reported Q4 revenue of $91 million, beating the $76.5 million consensus estimate by 19%.
The Edmonton-based cannabis producer posted earnings per share of $0.10, compared with the -$0.09 consensus estimate, according to the company's June 11 earnings release. The results mark a swing to profitability from the loss analysts had projected.
Revenue of $91 million exceeded the $76.5 million analysts had forecast by $14.5 million, while EPS of $0.10 reversed the expected loss of $0.09 per share. The beat was driven by stronger-than-anticipated sales across the company's premium cannabis segments.
The Q4 performance represents a significant improvement from prior periods, with revenue topping estimates by $14.5 million. The company swung from a projected loss to positive EPS, reflecting the impact of its operational restructuring and focus on higher-margin products.
Aurora's results come as the Canadian cannabis industry continues to consolidate, with producers prioritizing profitability over market share. The company's ability to beat both top-line and bottom-line estimates may strengthen investor confidence in its turnaround strategy.
The company did not disclose forward guidance in the earnings release. Analysts will watch for updates on international expansion plans and domestic market share trends when management hosts its earnings call.
The earnings beat signals that Aurora's cost-cutting and premium strategy is gaining traction. Investors will look to the Q1 FY2027 outlook for evidence of sustained margin improvement and revenue growth.
This article is for informational purposes only and does not constitute investment advice.
© 2026 Edgen Powered by